Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Will PTSC announce it now has a controlling interest in PDS?

No! Remember what Brian said, it's about control. For PDS to be in "control" would be in the best intrest of PTSC shareholders.

Share
New Message
Please login to post a reply